期刊文献+

Synthesis and biological evaluation of nitric oxide-releasing sixalkoxyl biphenyl derivatives as anticancer agents 被引量:5

Synthesis and biological evaluation of nitric oxide-releasing sixalkoxyl biphenyl derivatives as anticancer agents
下载PDF
导出
摘要 A series of novel nitric oxide-donating sixalkoxyl biphenyl derivatives (14a-1) were synthesized by coupling furoxan with alkoxyl biphenyl skeleton using amino acids as the spacers, and their cytotoxicity against HepG2 cells in vitro were evaluated by MTT method. It was found that 14c, 14d, 14f, 14i, 14j and 14k showed more potent cytotoxic activities than control 5-fluorouracil. NO release assay of target compounds indicated that the maximum amount of NO released by most active compounds 14c and 14j was about 6 × 10^-2 μmol/L, whereas 14a and 14h with very weak activity only released NO of 1 × 10^-2 μmol/L. A series of novel nitric oxide-donating sixalkoxyl biphenyl derivatives (14a-1) were synthesized by coupling furoxan with alkoxyl biphenyl skeleton using amino acids as the spacers, and their cytotoxicity against HepG2 cells in vitro were evaluated by MTT method. It was found that 14c, 14d, 14f, 14i, 14j and 14k showed more potent cytotoxic activities than control 5-fluorouracil. NO release assay of target compounds indicated that the maximum amount of NO released by most active compounds 14c and 14j was about 6 × 10^-2 μmol/L, whereas 14a and 14h with very weak activity only released NO of 1 × 10^-2 μmol/L.
出处 《Chinese Chemical Letters》 SCIE CAS CSCD 2008年第2期149-152,共4页 中国化学快报(英文版)
关键词 Nitric oxide-donating sixalkoxyl biphenyl derivatives FUROXAN CYTOTOXICITY Nitric oxide-donating sixalkoxyl biphenyl derivatives Furoxan Cytotoxicity
  • 相关文献

参考文献15

  • 1[1]J.X.Xie,J.Zhou,C.Z.Zhang,et al.Acta Pharm.Sin.17 (1)(1982)23.
  • 2[2]W.L.Wu,S.E.Chen,W.L.Chang,et al.Eur.J.Med.Chem.27 (4)(1992)353.
  • 3[3]D.F.Chen,S.X.Zhang,L.Xie,et al.Bioorg.Med.Chem.5 (8)(1997)1715.
  • 4[4]J.B.Chang,R.F.Chert,R.Y.Guo,et al.Helv.Chim.Acta 86 (2003)2239.
  • 5[5]A.Alam,Y.Takaguchi,H.Ito,et al.Tetrahedron 61 (2005)1909.
  • 6[6]R.Y.Guo,J.B.Chang,R.F.Chen,et al.Acta Pharm.Sin.34 (6)(1999)439.
  • 7[7]S.X.Chang,L.M.Wang,J.B.Chang,et al.Chin.J.Org.Chem.24 (6)(2004)691.
  • 8[8](a)Y.C.Hou,A.Janczuk,P.G.Wang,Corr.Pharm.Des.5 (1999)417;(b)P.G.Wang,M.Xian,X.Tang,et al.Chem.Rev.102 (2002)1091.
  • 9[9]J.J.Kerwin,M.Heller,Med.Res.Rev.14 (1)(1994)23.
  • 10[10]Q.Jia,A.J.Janczuk,T.Cai,et al.Expert Opin.Ther.Pat.12 (2002)819.

同被引文献17

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部